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Regulation of manganese superoxide dismutase in glomerular epithe-
hal cells: Mechanisms for interleukin 1 induction. Reactive oxygen
species have been implicated as mediators of tissue injury in glomerular
inflammation. The expression of the antioxidant enzyme, manganese
superoxide dismutase (MnSOD), was examined in primary cultures of rat
glomerular epithelial cells (GEC) in response to inflammatory mediators.
The results demonstrate that GEC respond to interleukin-1 (IL-i) and
bacterial lipopolysaccharride (LPS) with an increase in MnSOD steady-
state mRNA levels. The IL-la-mediated induction of MnSOD mRNA
levels was both time- and dose-dependent. Maximal levels, approximately
40-fold above controls, were observed at 12 hours with 2 ng/ml of IL-la.
MnSOD protein levels were also markedly elevated by IL-la. The
induction of MnSOD mRNA by IL-la required de novo transcription as
well as some degree of protein synthesis. To elucidate the potential
intracellular signal that mediates IL-la-dependent MnSOD expression,
three classical signaling pathways were examined. We found no evidence
that MnSOD induction by IL-la is mediated by either the cyclooxygenase
or lipoxygenase pathway or via activation of protein kinase C. Based on
the presence of IL-la in several forms of glomerular inflammation, the
observed increase in MnSOD expression by this immunoregulatory cyto-
kine must have an important role in the antioxidant defense of glomerular
epithelial cells.
The renal glomerular epithelial cell (GEC) is an integral
component of the three-layered ultrafiltration barrier of the
glomerular capillary. This cell is affected in several forms of
human and experimental glomerulonephritis. Morphological
changes of the GEC and impairment of filtration are observed in
glomerular diseases such as minimal change disease and most
types of glomerulonephritis, and in a variety of experimental
models of renal injury, such as puromycin and adriamycin nephro-
sis, and Heymann nephritis [1].
Reactive oxygen species (ROS) have been recognized increas-
ingly as potential mediators of inflammatory cell injury during
glomerulonephritis [2]. The inherent cellular protection against
ROS consists of a distinct antioxidant system. The superoxide
dismutases are the enzymes which detoxify the primary product of
ROS generation, the superoxide anion radical, leading to the
production of hydrogen peroxide. This reactive oxygen species is
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detoxified through the action of catalase or glutathione peroxi-
dase [3].
It has also been observed that with glomerular inflammation
there is increased expression of the inflammatory cytokines,
interleukin-l (IL-i) and tumor necrosis factor a (TNFa) [4—9].
Recently, we and others have found a correlation between the
action of these cytokines and the expression of the mitochondrial
antioxidant enzyme, manganese superoxide dismutase (MnSOD).
Those data demonstrated that steady-state MnSOD mRNA levels
are induced following treatment with IL-i and TNFa, as well as
with bacterial lipopolysaccharide (LPS) in various cell lines,
whereas mRNA levels for the cytosolic copper/zinc superoxide
dismutase (Cu/ZnSOD), catalase, and glutathione peroxidase
were unaltered in response to these same stimuli [10—12]. How-
ever, the induction of MnSOD by these inflammatory mediators is
not observed in all cell types. In hepatocytes, for example, only
interleukin 6 induced an increase in MnSOD mRNA levels [13].
In addition, Fujii and Taniguchi [14] have demonstrated that
MnSOD levels are not elevated by TNF, IL-i, or LPS in TNF-
sensitive human tumor cell lines.
To better understand the antioxidant system of the glomerulus,
the current study examined the effects of several proinflammatory
mediators on MnSOD and Cu/ZnSOD mRNA levels in primary
cultures of the rat GEC. Increased steady-state MnSOD mRNA
levels were observed following treatment with IL-la and 3, and
LPS, but not in response to TNFa and IL-6, thus further
demonstrating cell-specific MnSOD regulation. Since the signal
transduction mechanism by which IL-i induces MnSOD gene
expression is not yet understood, we also evaluated the possible
role of membrane phospholipid metabolites and protein kinase C
(PKC) in the intracellular signaling of IL-i.
Methods
Glomerular epithelial cell culture
Primary cultures of the rat GEC were initiated according to
established protocols [15]. Briefly, kidneys were removed from
150 to 200 g male Sprague Dawley rats, and cortices were
dissected and diced with a razor blade. The minced cortices were
passed sequentially through 250 p., 106 /.L, and 75 p. stainless steel
sieves to isolate glomeruli. After 30 minutes of treatment with 180
U/mI collagenase (Worthington Biochemical Corp., Freehold, NJ,
USA), glomeruli were suspended in K1—3T3 (50:50; vol/vol)
medium [15] and plated onto 100 mm Petri dishes (Becton
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Detroit, MI), common leukocyte antigens (LCA, Dako-LC, Dako
Corp., Carpintesia, CA; and T29/33, Hybritech, San Diego, CA,
USA), and actin (Enzo Diagnostics, Inc., New York, NY, USA).
It is currently not possible to determine specifically whether GEC
in culture originate from the visceral or parietal epithelium [1].
However, since the majority of glomeruli isolated from the tissue
are decapsulated after sieving [15], we believe the cells are most
likely of visceral origin.
Experimental stimuli and inhibitors
Fig. 1. Effect of different inflammatoty mediators on MnSOD mRNA and
Cu/ZnSOD mRNA levels. Glomerular epithelial cells were treated for 12
hours with 2 ng/ml IL-la or (3, 100 U/nil IL-6, 10 ng/ml TNFa, or 0.5 g/ml
LPS. The Northern blot was probed with a MnSOD cDNA, Cu/ZnSOD
eDNA, and with a cathepsin B eDNA. mRNA levels were quantified
densitometrically relative to the intensity of the cathepsin B signal.
I collagen matrix layer. The primary outgrowth observed after six
days was excised with a razor blade, and transferred to 24-well
culture dishes also coated with collagen. Further subcultures were
performed in culture vessels of gradually increased size. For all
subcultures, cells were rinsed with Ca, Mg free HBSS
(Sigma, St. Louis, MO, USA), collagenase-treated 180 U/ml for
30 minutes to dissolve the collagen matrix, trypsinized with 0.05%
trypsin (Sigma) in 0.5 mvi EDTA Ca ,Mg free HBSS for five
minutes, resuspended in K1—3T3 culture medium and plated on
the collagen matrix. For experiments, cells were plated on 100 mm
Petri dishes and were studied after they formed a confluent layer.
Passages 8 to 15 were used for all experiments.
Growth characteristics of the GEC were determined and the
seeding efficiency was found to be 35%, with a population
doubling time of 24 hours. Cells grew poorly in media lacking
conditioned Swiss 3T3 fibroblast medium and permanent culture
of the GEC was not possible without the use of a collagenous
substrate.
The cells were characterized according to established criteria
[15, 16]. Cells exhibited a polygonal shape and a cobblestone-like
appearance at confluency. Immunohistochemical staining was
positive with an antibody against cytokeratin (Amersham Corp.,
Arlington Heights, IL, USA), and was diffusely positive with an
antibody against myosin (Biogeninex, Dublin, CA). The cells were
negative for markers of other glomerular cell types such as factor
VIII endothelial antigen (von Willebrand's factor; Immunon,
The cytokines utilized were all human recombinant products.
IL-i a and f3 were obtained from an NCI-sponsored program.
TNFa was a gift from Genentech (Ca, USA); IL-6 was a gift from
Genetics Institute (Cambridge, MA, USA). Bacterial lipopolysac-
charide (E. coil endotoxin L2637, Sigma) as well as the cytokines
were dissolved in sterile water and added to the cell culture plates
at the dosages indicated in the Results section. The phorbol ester,
12-O-tetradecanoylphorbol 13-acetate (TPA), was dissolved in
dimethyl sulfoxide (DMSO) (both from Sigma) at varying con-
centrations in that a constant volume of TPA solution, 10 l/10 ml
medium, was required to give the desired final TPA concentration
in the culture medium as indicated in the Results section.
Actinomycin D at a concentration of 4 M and cycloheximide at a
concentration of 20 M (Sigma) were employed to inhibit RNA
synthesis and protein synthesis, respectively.
Indomethacin, nordihydroguaiaretic acid (NDGA) and 1-phe-
nyl-3-pyrazolidone (Sigma) were dissolved in absolute ethanol.
5-,12-,15-(S)-Hydroxyeicosatetraenoic acid and the leukotrienes,
LTB4, LTC4, LTD4, were obtained from Sigma, and the 5-,12-,
15-(S)-Hydroperoxyeicosatetraenoic acid from Cayman Chemical
(Ann Arbor, MI, USA).
Evaluation of steady-state mRNA levels
RNA isolation and Northern blotting. Total cellular RNA was
isolated by the acid guanidinium thiocyanate-phenol-chloroform
extraction method [17]. Samples of 15 g of total cellular RNA
were dissolved in 25 j.d of buffer containing 50% (vol/vol)
formamide, 6.4% formaldehyde, 20 mM/liter morpholinepropane-
sulfonic acid (MOPS), 6 mM/liter sodium acetate, and 0.5 mM/liter
EDTA (pH 7.0). RNA samples were denatured at 65° for 15
minutes and 5 il of a 1.2 mM/liter ethidium bromide solution was
added. The RNA was fractionated by size on a 1% agarose, 6%
formaldehyde gel. The RNA was electrotransferred to a non-
charged nylon membrane (Genescreen, DuPont-New England
Nuclear, Boston, MA, USA) and covalently cross-linked to the
membrane with UV light [101.
Hybridization with cDNA probes. The membrane was prehybrid-
ized in 0.45 M sodium phosphate, 7% sodium dodecyl sulfate, 1
mM EDTA, and 1% bovine serum albumin for 20 minutes. The
membrane was hybridized for 16 hours at 60°C in the above
hybridization solution with a 32P-labeled rat MnSOD cDNA, a rat
Cu/ZnSOD eDNA, rat preprocathepsin B cDNA (a gift from S.J.
Chan, University of Chicago), or a rat c-fos cDNA (a gift from T.
Curran, Roche Institute, Nutley, NJ, USA). The two rat cDNA
probes for MnSOD and Cu/ZnSOD were 936 and 650 base pairs,
respectively. They have been isolated in our laboratory and will be
described in more detail elsewhere. Northern analysis using
primarily coding sequence from a MnSOD cDNA demonstrated
the presence of five transcripts (Fig. 1). Based on studies in our
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Fig. 2. A. Time-dependent increase of MnSOD mRNA levels in the GEC
A following treatment with 2 nglml IL-la. B. Quantitative summaiy of these'°
experiments. The MnSOD mRNA levels of treated cells are expressed as
Time, hours N-fold increases above the mRNA levels of the untreated controls. N =3.
laboratory, we have shown that these transcripts represent alter- 50
natively polyadenylated products [18].
Densitometty. CuIZnSOD, MnSOD, and preprocathepsin B
mRNA levels were quantified using the Bio Image Visage 60 40
video densitometry system (Millipore/Bio Image, Ann Arbor, MI,
USA). Densitometry for quantitation of the autoradiographs was
performed only on the two most abundant transcripts. For all
experiments, quantitative data were presented only on signals in
the linear range of the film and the densitometer. Individual lanes
were compared with respect to the intensity of the preproca-
thepsin B signal, that is, the data are expressed as a ratio of
MnSOD/preprocathepsin B. Numbers represent the mean SD,
where given, from at least three independent experiments, unless
otherwise stated.
Detection of MnSOD protein
Cells were harvested at specific time intervals following IL-la
treatment together with their appropriate controls. Cell culture
medium was not exchanged between IL-la application and cell
harvesting. To harvest cells, plates were collagenase-treated as
described in GEC culture, washed four times with ice-cold 20 ml




Fig. 3. Densitometric data on the dose-dependent induction of MnSOD
mRNA levels in glomerular epithelial cells treated with IL-la for 12 hours
relative to the untreated controls. N = 2.
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Fig. 4. Time-dependent accumulation of
MnSOD protein in glomerular epithelial cells
treated with 2 ng/ml IL-1c
HBSS and resuspended in 0.5 ml of a pH 7.5, 0.25 M sucrose, 10
mM Tris, 1 mi EDTA solution. Then, 20 .tM phenylmethyl
sulfoxide and 10 ig/ml protamine were added to the samples.
Samples were incubated with 2% Triton X-100 for five minutes,
homogenized, and centrifuged at 1000 rpm for five minutes at 4°C.
The total protein content was determined in the supernatant [19j
and samples of 10 g protein were applied to a SDSI15%
acrylamide gel for separation of proteins under reducing condi-
tions [20]. The samples were blotted to nitrocellulose using the
buffer system described by Towbin, Staehelin and Gordon [21].
The membrane was probed with a 1:1000 dilution of rabbit
polyclonal antibody against rat MnSOD [221. The bound primary
antibody was detected with the enhanced chemiluminescence kit
from Amersham Corp.
Results
The response of the GEC to specffic cytokines and LPS is
depicted in Figure 1. Untreated cells exhibited low steady-state
MnSOD mRNA levels, whereas IL-la and J3 caused a 49-fold and
35-fold increase, respectively, in MnSOD mRNA when compared
to the untreated controls. LPS increased MnSOD mRNA levels
by 18-fold. Unlike glomerular mesangial cells, the GEC did not
respond to TNFa (Fig. 1), even when used at doses as high as 100
ng/ml (Nick and Gwinner, unpublished observations). In addition,
IL-6 did not change MnSOD mRNA levels.
To determine the effect of these stimuli on Cu/ZnSOD mRNA
levels in the GEC, the membrane was reprobed with the corre-
sponding cDNA. As shown in Figure 1, none of the stimuli altered
Cu/ZnSOD mRNA levels. We have found that preprocathepsin B
(cathepsin B) mRNA levels in the GEC are constant under most
experimental conditions. Therefore, loading variations and den-
sitometric quantitations were determined relative to cathepsin B
mRNA levels.
Because of the importance of IL-i in glomerular inflammation,
we concentrated our efforts on the effects of IL-la on MnSOD
mRNA induction. Figure 2 A and B demonstrate that the induction
of MnSOD mRNA levels by IL-ia is time-dependent with a
maximal response at 12 hours, although some variability was
observed among the five transcripts. The induction of MnSOD
mRNA was also dose-dependent as depicted in Figure 3. In these
12 hour experiments, maximal induction was seen at a concentra-
tion of 2 ng/ml IL-la, but a dose as low as 0.25 ng/ml, correspond-
ing to 15 p, was still effective. Based on these results with IL-la,
a dose of 2 ng/ml was utilized for the subsequent studies.
Figure 4 illustrates the effect of IL-la on MnSOD protein levels
at specific time points after treatment, as determined by Western
analysis. At 12 hours the protein levels were maximal and
remained high throughout the entire observation period of five
days.
To determine whether the induction of MnSOD mRNA by
IL-ia required new transcription, cells were co-treated with IL-la
and the transcriptional inhibitor, actinomycin D, at a dose of 4 M
(Fig. 5A). Actinomycin D abolished the IL-la-mediated increase
in MnSOD mRNA, indicating that this induction is dependent on
de nova mRNA synthesis.
Cells were also co-treated with IL-la and the protein synthesis
inhibitor, cycloheximide. As depicted in Figure SB, cycloheximide
did not prevent the IL-la-dependent increase. However, the
MnSOD mRNA levels were lower when compared to treatment
with IL-la alone. These results indicate that new protein synthesis
is not a strict prerequisite for the IL-la-dependent induction of
MnSOD mRNA. The reduced level of MnSOD mRNA observed
after the co-treatment with IL-la and cycloheximide could indi-
cate a requirement for protein synthesis for maximal MnSOD
mRNA induction. Furthermore, we interpret the higher cathep-
sin B mRNA level observed in cycloheximide-treated cells as an
actual increase in cathepsin B mRNA levels presumably due
to mRNA stabilization by cycloheximide, especially since the
ethidium bromide staining indicated comparable loading in every
experiment.
There are several potential intracellular signaling pathways for
IL-i action including: phospholipase A2 activation resulting in the
release of arachidonic acid metabolites as second messengers
[23, 24]; activation of phospholipase C [25}; and/or activation of
protein kinase C (PKC) [26]. In an attempt to elucidate the
intracellular signaling mechanism by which IL-la induces in-
creased MnSOD mRNA levels, the involvement of cyclooxygen-
ase or lipoxygenase-derived arachidonic acid metabolites in the
IL-la mediated MnSOD induction was evaluated. Cells were
treated with either 50 /.LM indomethacin to inhibit the cyclooxy-
genase, or 20 to 30 tM nordihydroguaiaretic acid (NDGA) to
inhibit lipoxygenases, followed by the addition of IL-la for 6 or 12
hours. Compared to IL-la treatment alone, treatment with indo-
methacin did not inhibit the IL-la-mediated induction of MnSOD
mRNA levels (data not shown). Treatment with NDGA at both 20
j.LM and 30 tM failed to decrease the IL-la-induction of MnSOD
mRNA which is demonstrated for the 12-hour incubation period
in Figure 6. In addition, another lipoxygenase inhibitor, 1-phenyl-
3-pyrazolidone (50 LM), also showed no inhibition on the IL-la-
mediated MnSOD induction (data not shown).
In another study, Haliday, Ramesha and Ringold [27] demon-
strated that TNFa, which shares many similar biological effects
with IL-i, induced the protooncogene, c-fos, in adipocytes via
metabolites of arachidonic acid. The TNFa-mediated c-fos induc-
tion could be blocked by lipoxygenase inhibitors, whereas the
lipoxygenase products, 5-,12-, or l5-hydroperoxyeicosatetraenoic
acid (HPETES), could mimic the increase in c-fos mRNA.
Therefore, we examined a number of lipoxygenase metabolites for
IL-la — + — +
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these lipids, incubation periods of two and six hours were selected.
In the case of 5-,12-, and 15-HPETES which are radicals, one and
four hour time points were also examined. Using concentrations
of 0.1 j.LM and 1.0 /LM of 5-,12-, and 15-HETE, 5-,12-, and
15-HPETE, and of the different leukotrienes, no changes in
MnSOD mRNA levels were observed at any time point (data not
shown).
Fig. 5. Effect of the transcriptional inhibitor, actinomycin D (A), and the
protein synthesis inhibitor, cycloheximide (B) on the IL-la-mediated
MnSOD mRWA induction. Ulomerular epithelial cells were treated for 12
hours with 2 ng/ml IL-la alone or co-treated with IL-la and 4 jsM
actinomycin D or 20 LM cycloheximide, respectively.
their ability to mimic IL-i-dependent MnSOD expression includ-
ing 5-,12-, and 15-HPETES as well as the more stable metabolites,
5-,12-, and 15 hydroeicosatetraenoic acid (HETE); and the leu-
kotrienes B4, C4, and D4. Because of the potential instability of
To examine the potential role of protein kinase C (PKC)
activation in the IL-la-mediated induction of MnSOD mRNA
levels, PKC activity was down-regulated in the GEC by the
phorbol ester TPA. It is well established that short-term treatment
with TPA induces PKC activity and that high doses over a
prolonged period deplete most types of PKC activity [28]. There-
fore, we first examined whether an 18-hour treatment with 2.4 ILM
TPA was sufficient to down-regulate PKC. In these experiments,
c-fos mRNA levels were used as an indicator of PKC activity,
because it has been shown that c-fos mRNA can be induced by
PKC activation [28}. Figure 7 demonstrates that stimulation of
PKC by 0.4 sM TPA causes a rapid and transient induction of
c-fos mRNA at 0.5 hours with a maximum at one hour (left panel).
However, following an 18 hour pre-treatment with 2.4 M TPA,
c-fos mRNA could not be induced by 0.4 M TPA (right panel),
indicating a significant down-regulation of PKC activity. Figure 7
also depicts the same blot reprobed with MnSOD cDNA. As seen
in the left panel, treatment with 0.4 M TPA caused a sixfold
induction of MnSOD mRNA levels within six hours, similar to
results recently shown in pulmonary cells [29]. Lower doses of
TPA between 10 to 150 n were also capable of inducing MnSOD
mRNA levels (data not shown), but 0.4 M exhibited the greatest
and most consistent response. In comparison to the rapid increase
and destabilization of c-fos mRNA following TPA treatment, the
MnSOD induction was delayed and elevated levels were sustained
for six hours. Furthermore, elevated MnSOD levels were even
observed after 18 hours of pretreatment with 2.4 .tM TPA, as
shown in the control lane in the right panel of Figure 7. Following
re-exposure of TPA pretreated cells to 0.4 jM TPA, no further
increase in MnSOD mRNA levels was observed, suggesting a
possible role for PKC activation in MnSOD gene activation by
TPA.
We next examined the involvement of PKC activation in the
IL-la-mediated induction of MnSOD mRNA. The left and
middle panel of Figure 8A shows either control cells or cells
pretreated with the vehicle, respectively, in combination with the
various stimuli. As is evident from the right panel of Figure 8A
and the quantitative summary in Figure 8B, PKC down-regulation
by TPA did not change the ability of IL-la to induce MnSOD
mRNA levels in these cells. Similar results were obtained for LPS,
indicating that neither IL-la nor LPS-mediated MnSOD induc-
tion is dependent on PKC activation.
Discussion
ROS have been implicated increasingly as mediators in tissue
injury in several forms of inflammatory glomerular disease [2].
The likely mechanism of this injury is based on the damage of
cellular components such as DNA, cellular proteins and lipids by
ROS, ultimately resulting in cell dysfunction and death [30].
The present study focuses on the regulation of the superoxide
dismutases, the primary cellular defense against ROS, in cultured
GEC. We found marked stimulation of MnSOD mRNA steady-
state levels in the GEC after treatment with either IL-la, /3, or
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Fig. 6. Effect of lipoxygenase inhibition on IL-
la-mediated MnSOD mRNA induction.
Glomerular epithelial cells were treated for 30
minutes with the vehicle (lanes 1 and 2),
ethanol (lanes 3 and 8), 20 M NDGA (lanes 4
and 9), and 30 M NDGA (lanes 5 and 10).
Subsequently, the cells were incubated for 12
hours with 2 nglml IL-la as indicated by (+).
Lanes 6 and 7 were treated only with IL-la to
demonstrate the usual level of MnSOD
induction.
Fig. 7. illustration of PKC down-regulation in the GEC as demonstrated by the inability to induce c-fos mRNA with 0.4 i1 TPA (right panel) as opposed
to the c-fos mRNA induction by 30 or 60 minutes treatment with 0.4 M TPA in cells without prior PKC down-regulation (left panel). PKC down-regulation
was achieved by 18 hours of pretreatment with 2.4 M TPA. The same blot reprobed with the MnSOD cDNA shows a time-dependent increase in
MnSOD mRNA levels after TPA treatment.
LPS. Unlike mesangial cells, GEC did not respond to the inflam-
matory mediator, TNFa. This observation is also in contrast to
results in other epithelial cell lines originating from the lung [10]
and small intestine [11], where TNFa caused large increases in
MnSOD mRNA levels. Similar to the IL-6-speciflc induction of
MnSOD in hepatocytes [13], our results in glomerular epithelial
cells are therefore another example of the cell type-specific
regulation of MnSOD. In agreement with previous observations,
none of the stimuli increased Cu/ZnSOD mRNA levels 110—121,
indicating that at least under these circumstances the constitutive
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expression of this antioxidant enzyme may be adequate for its
protective role in the cytoplasm.
Several observations support an important role for IL-i in
inflammatory glomerular disease. IL-i expression in kidney tis-
sue is enhanced in experimental immune complex nephritis [4],
puromycin nephrosis [5], anti-GBM nephritis [6], lupus nephritis
[7], and in glomerular cell cultures from patients with rapidly
progressive crescentic glomerulonephritis [8]. Therefore, further
studies were performed using IL-ia. The IL-la-mediated in-
crease in MnSOD mRNA was both dose- and time-dependent.
Furthermore, we have also demonstrated the time-dependent
accumulation of MnSOD protein following IL-la treatment in the
GEC. With regard to the physiological significance of this re-
sponse, in vitro observations provide evidence that elevated SOD
protein levels confer resistance against ROS damage in mamma-
lian cells and, conversely, lack of inducible SOD genes rendered
the cells more sensitive to oxidative damage [31, 32]. In addition,
in vivo experiments with transgenic mice, expressing enhanced
MnSOD protein levels, demonstrated protection against other-
Fig. 8. A. Comparison of induced MnSOD mRt'JA levels in glomerular
epithelial cells with or without PKC down-regulation. Cells not depleted of
PKC activity (left portion), or pretreated for 18 hours with DMSO, the
vehicle for TPA (middle portion), or pretreated for 18 hours with 2.4 sM
TPA (right portion), were incubated with 2 ngfml IL-la, 0.5 sgJml LPS,
DMSO, or 0.4 jLM TPA for a six hour period. B. Quantitative summary of
the densitometric data of three independent experiments as described in
A. Symbols are: (•) control; () IL-la; (0) LPS; (B) DMSO; () TPA.
wise lethal hyperoxia [33]. In the kidney, glomerular antioxidative
enzymes including MnSOD are moderately induced by steroids
and this induction conferred protection in puromycin amino-
nucleoside nephrosis [34].
The mechanism by which IL-i induces an increase in MnSOD
in mRNA is not yet understood. However, since IL-i has been
shown to interfere with mitochondrial respiration by inhibiting
mitochondrial aconitase [35, 36], the potential importance of the
regulation of MnSOD that is localized specifically to mitochon-
dna is more easily understood. Our results in GEC co-treated
with IL-ia and actinomycin or cycloheximide indicate that de
novo mRNA transcription is required as well as some degree of
new protein synthesis. This is further supported by nuclear run-on
studies which demonstrate that MnSOD gene transcription is
enhanced in response to IL-la (Hsu and Nick, unpublished
observations). These data suggest that the induction of MnSOD
gene expression by IL-la occurs via the generation of an intra-
cellular signal that may alter a pre-existing transcription factor, as
has been described for interferon a-induced effects [37]. The
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transcription factor then presumably enhances transcription by
binding to the MnSOD promotor or by releasing a repressor
molecule from the promotor.
To further characterize the mechanism controlling IL-i- medi-
ated induction of MnSOD, we examined potential intracellular
signaling pathways. Of the known pathways associated with IL-i-
induced effects in different cell types, no single unifying mecha-
nism has been identified. IL-i has been shown to induce the
production of the lipoxygenase metabolites 5-, and 15-HETE in T
cells. Lipoxygenase activity was also found to be necessary in
IL-i-mediated IL-2 production in these cells, as demonstrated by
studies with a lipoxygenase inhibitor [24}. In addition, Mufloz et al
[26] have recently demonstrated that IL-i-dependent induction of
IL-5 in T cells is mediated by protein kinase C.
Therefore, we evaluated the potential role of lipoxygenase as
well as cyclooxygenase metabolites as an intracellular signal for
MnSOD expression in the GEC. With regard to our studies, these
metabolites are synthesized by GEC [38, 39]. Our experiments
with the cyclooxygenase inhibitor, indomethacin, indicate that
cyclooxygenase metabolites are not necessary for the IL-la induc-
tion of MnSOD. Also, the lipoxygenase inhibitor, NDGA, had no
suppressive effect on the IL-ia induction of MnSOD mRNA
levels. In addition, the cells were treated with a number of
metabolites from the lipoxygenase pathway to evaluate whether
these substances could mimic IL-la in inducing the MnSOD
mRNA levels. We were unable to demonstrate an increase in
MnSOD mRNA following incubation with either 5-,12-, or 15-
HETE, 5-,12, or 15-HPETE, or the leukotrienes, LTB4, LTC4,
LTD4. Moreover, we could not detect any increase in c-los
mRNA at one hour following treatment with 5-, 12-, or 15-
HPETE (data not shown) as observed in adipocytes by Haliday et
al [27], even though c-fos mRNA can be induced by TPA in GEC
(Fig. 8). In conclusion, our experiments with lipoxygenase metab-
olites do not provide evidence that these substances are involved
in MnSOD gene induction in GEC.
As indicated above, activation of PKC may also be involved in
the intracellular signaling pathway of IL-i [26]. In addition, IL-i
increases the generation of diacylglycerol, a co-factor of PKC,
from membrane phospholipids in a number of cell types [25, 40].
Therefore, we examined whether down-regulation of PKC activity
would abolish the IL-ia-dependent induction of MnSOD mRNA
levels. Our results in PKC-depleted GEC (Fig. 8A and 8B)
demonstrate that PKC activity is not required for the IL-la-
mediated MnSOD mRNA induction. The induction of MnSOD
mRNA observed after TPA-treatment may be an alternative
means of MnSOD gene induction, presumably mediated by PKC
as suggested recently by another group [14].
In conclusion, we have shown that GEC respond to IL-i and
LPS with a dramatic increase in MnSOD expression. The intra-
cellular signaling mechanism of IL-i-mediated MnSOD induction
presumably does not involve metabolites of the cyclooxygenase
and lipoxygenase pathway, or PKC activation. These results
suggest that IL-i must employ a novel signaling pathway for the
induction of this important mitochondrial-localized antioxidant
enzyme. Based on the central role of IL-i in glomerular inflam-
mation, the IL-i-induced MnSOD expression in GEC we have
demonstrated in vitro might have important implications for the
cellular defense against ROS toxicity.
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